Tuesday, 19 March 2024
  
Login

Australia's most trusted
source of pharma news

Tuesday, 19 March 2024
Ascott IQVIA 1
Ascott IQVIA 1
Boss takes crushing pay cut

After a rough year in the wake of plummeting demand for its products, this CEO's pay was slashed by an eye-watering AU$17.3 million in 2023, but he's still quite a way from the breadline, taking home AU$32.8 million.

ViiV closing the care gap
$200,000 grants program supports HIV community needs
TODAY
Which patient groups rate pharma?
Depending on disease area industry wins a thumbs up... or down
TODAY
BMS wins a first in CAR-T
New niche for therapy overseas but still no appearance locally
TODAY
What doctors want from pharma
Seven things pharma can do for Aussie HCPs
18 March
Where women are the top earners
Pharmas boasting the most women in the top pay bracket
15 March
CEO doubles pay 1 year into the job
At $40m he might be pharma's new highest paid boss
15 March
Why two in five new hires turn 'bad'
And how one Aussie pharma recruiter is fighting the statistic
14 March
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (13)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (2)

Other (34)

Deal brings new drug to ANZ
Good news for paediatric population with high unmet need
TODAY
Seat at the PBAC table for patients
Dept releases draft proposals to improve HTA for consumers
TODAY
Aussie Big Pharma caught in scam
Social media promoting dodgy products with top brand name
18 March
AZ takes out Kosi Pharma Cup
Swoops in from second place for a first-time win
18 March
Global onco heads flown in
Company wants Australia as an innovation hub in oncology
18 March
New niche for checkpoint drugs
Aussie-led study kicks off a new approach to CPI therapy
18 March
New acne drug approved
Marking the first new mechanism of action in decades
18 March Approvals Action
Retirement beckons for Aussie GM
ICYMI: The stories that topped this week
15 March Your Week in Five Minutes
Market access exec wins board role
Former long-time Janssen staffer to offer industry insights
15 March
BMS blockbuster around for longer
Patent extension shorter than hoped but better than nothing
15 March
Merck grows fertility benefit
Australian employees offered access to a range of services
15 March
Guild wins extra $3 billion in 8CPA
After months of bitter skirmishes, parties strike a deal
14 March
Industry leader to step down
Announces retirement after 14 years as CEO
14 March
Comms boss returns to pharma
And who's leaving the industry after 22 years?
14 March
PiF jobs
PiF jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.